Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes.
Soybean and its isoflavones have been shown to have beneficial effects on carbohydrate and lipid metabolism and on renal function. Probiotics may potentiate the beneficial effects of isoflavones by converting the inactive isoflavone glycoside to aglycones, which are biologically active, thereby producing a synergistic effect. We therefore studied the effects of soybean isoflavones in the presence and absence of probiotics on glucose and triglyceride metabolism and the peptide hormones involved in their metabolism. Lean and obese SHR/N-cp rats were fed AIN-93 diets containing 0.1% soybean isoflavone mixture, 0.1% probiotics mixture or both. Plasma was analyzed for glucose, triglycerides, parameters of renal function and peptide hormones -- insulin, leptin, glucagon and ACTH -- that are involved in glucose and lipid metabolism. Isoflavones given alone lowered plasma glucose in both phenotypes while triglyceride was decreased only in lean animals. Isoflavones also lowered aspartate amino transferase and alanine amino transferase in both phenotypes. Isoflavones had significant effect on plasma insulin, leptin and glucagon in lean rats but not in obese rats. Thus, our data show that in lean animals, isoflavones have hypoglycemic and hypolipidemic effect, and the effect is mediated by changes in peptide hormones. When lipid levels are very high as in obese rats, isoflavones fail to lower plasma triglyceride levels. Probiotics do not appear to enhance the effect of isoflavones.
Ali
Ali A
AA
Phytonutrients Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture, MD 20705, USA.
Velasquez
Manuel T
MT
Hansen
Carl T
CT
Mohamed
Ali I
AI
Bhathena
Sam J
SJ
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D050260:Carbohydrate Metabolism / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy / Q000628:therapy*; D005934:Glucagon / Q000097:blood; D007328:Insulin / Q000097:blood; D007529:Isoflavones / Q000494:pharmacology*; D020738:Leptin / Q000097:blood; D008297:Male; D009765:Obesity / Q000097:blood* / Q000188:drug therapy / Q000628:therapy*; D036361:Peptide Hormones / Q000097:blood*; D048789:Phytoestrogens / Q000494:pharmacology; D019936:Probiotics / Q000494:pharmacology*; D051381:Rats; D011918:Rats, Inbred SHR; D013025:Glycine max / Q000737:chemistry*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D007529:Isoflavones; D020738:Leptin; D036361:Peptide Hormones; D048789:Phytoestrogens; D014280:Triglycerides; D000324:Adrenocorticotropic Hormone; D005934:Glucagon